Is Cap Assisted Endoscopy Useful in Acute Upper Gastrointestinal Bleeding ?
CAP
1 other identifier
interventional
72
1 country
1
Brief Summary
High digestive bleeding (HDH) is a medical emergency associated with high morbidity and mortality rates and significant healthcare costs. Upper endoscopy can locate the bleeding and treat it. However, the source of bleeding can be difficult to identify, even for the most experienced endoscopists, due to the location of the bleeding (posterior wall of the bulb, gastric or duodenal folds, papillary region, esophagogastric junction), instability of the tube due to gastric and pyloric contractions and respiratory movements, leading to longer procedure times, hemostasis failure, or even the absence of bleeding visualization. The use of a cap attached to the endoscope facilitates exploration of blind areas of the colonic mucosa located behind folds, thus reducing the rate of missed polyps and cecal intubation time. To date, there is no study evaluating the systematic use of a cap in patients with suspected high digestive bleeding. A series of four cases demonstrated its benefit, allowing for better exposure of the bleeding lesion, better unfolding of intestinal folds, and thus a more effective and quicker hemostatic treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2025
CompletedFirst Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
December 5, 2025
November 1, 2025
12 months
November 17, 2025
November 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
procedure time until endoscopic hemostasis is achieved
procedure time until endoscopic hemostasis is achieved
1 month
Secondary Outcomes (7)
therapeutic success rate
1 month
clinical success rate
1 month
time until bleeding localization
up to 1 month
duration of hemostasis achievement
up to 1 month
endoscope stability
up to 1 month
- +2 more secondary outcomes
Study Arms (2)
standard upper endoscopy
ACTIVE COMPARATORstandard upper endoscopy
CAP
EXPERIMENTALupper endoscopy with the placement of an endoscopic cap
Interventions
All patients with the inclusion criteria will be randomized (randomization 1:1) to undergo either an upper endoscopy with an endoscopic cap or without a cap
All patients with the inclusion criteria will be randomized (randomization 1:1) to undergo either an upper endoscopy with an endoscopic cap or without a cap
Eligibility Criteria
You may qualify if:
- Patient \> 18 years old
- Upper GI bleeding suspected in presence of melena or hematemesis
- Glasgow Blatchford score \> 8
- Upper gastroscopy at Amiens University Hospital
- Follow-up at Amiens university hospital
- Presence of gastric or duodenal ulcer requiring endoscopic hemostasis (FORREST Ia, Ib, IIa, IIb)
- No opposition to the study
- No guardianship or curators
You may not qualify if:
- Patient with clinical suspicion of portal hypertension
- Known liver failure
- Patient with digestive hemorrhage related to a lesion located beyond the 2nd duodenum
- Patient with digestive hemorrhage related to a varicose lesion (esophageal or gastric varices)
- Patient with bleeding associated with esophagitis
- Patient with bleeding associated with angiodysplasias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire d'Amiens
Amiens, Picardie, 80000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
December 5, 2025
Study Start
October 16, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
December 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share